GE HealthCare Technologies Inc. $GEHC Shares Newly Bought by White Pine Capital LLC

White Pine Capital LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the third quarter, Holdings Channel reports. The firm acquired 7,149 shares of the company’s stock, valued at approximately $467,000.

Several other large investors also recently added to or reduced their stakes in GEHC. Bessemer Group Inc. raised its stake in shares of GE HealthCare Technologies by 8.8% during the third quarter. Bessemer Group Inc. now owns 7,405 shares of the company’s stock valued at $484,000 after acquiring an additional 598 shares in the last quarter. IFG Advisory LLC grew its stake in GE HealthCare Technologies by 21.3% in the third quarter. IFG Advisory LLC now owns 836 shares of the company’s stock worth $55,000 after purchasing an additional 147 shares in the last quarter. Phoenix Financial Ltd. grew its stake in GE HealthCare Technologies by 15.2% in the third quarter. Phoenix Financial Ltd. now owns 5,910 shares of the company’s stock worth $386,000 after purchasing an additional 779 shares in the last quarter. Wellington Grp LLC grew its stake in GE HealthCare Technologies by 68.9% in the third quarter. Wellington Grp LLC now owns 19,890 shares of the company’s stock worth $1,300,000 after purchasing an additional 8,115 shares in the last quarter. Finally, Aberdeen Group plc increased its holdings in GE HealthCare Technologies by 247.4% during the 3rd quarter. Aberdeen Group plc now owns 556,124 shares of the company’s stock worth $36,354,000 after purchasing an additional 396,044 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.1%

NASDAQ GEHC opened at $82.96 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a 50 day moving average price of $70.83 and a 200 day moving average price of $70.13. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. The firm has a market cap of $37.51 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 2.06 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.14. The company had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. GE HealthCare Technologies’s revenue was up 7.2% compared to the same quarter last year. During the same period last year, the firm earned $1.07 earnings per share. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were given a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, October 23rd. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.38%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on GEHC shares. Weiss Ratings raised GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 6th. Barclays upped their target price on GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, October 29th. Bank of America reissued a “neutral” rating on shares of GE HealthCare Technologies in a research report on Thursday, October 29th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Finally, Wells Fargo & Company raised their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $82.17.

Get Our Latest Analysis on GEHC

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Featured Articles

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.